secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0000950170-24-058626
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE Q1 net revenue $10.1M (down 3% YoY); reiterates FY2024 guidance
-----------------------------------------------------------------------

- Net revenue $10.1M, down 3% YoY; U.S. laser revenue down 22% to $2.7M.
- Gross margin improved to 33% (up 1 ppt YoY); operating loss narrowed 15% to $4.5M.
- Consumables revenue up 14% YoY; third strongest consumables quarter in company history.
- Adjusted EBITDA loss improved 21% to $3.5M ($0.20 per share) vs. $4.4M a year ago.
- Reaffirms FY2024 guidance: revenue $52-53M (6-8% growth) and positive Adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/0000950170-24-058626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/biol-20240513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-058626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer